language_icon
EN
HI

RPG Life Sciences Share price

RPGLIFE

2295

0.00 (0.00%)
NSE
BSE
Last updated on 30 Apr, 2026 | 15:49 IST
Today's High

2336.60

Today's Low

2049.90

52 Week Low

1733.00

52 Week High

2725.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

RPG Life Sciences Chart

RPG Life Sciences Share Key Metrics

Volume
16.83 L
Market Cap
3795.70 CR
LTQ@LTP
10@2295.00
ATP
2258.09
Var Margin
19.91 %
Circuit Range
1624.4-2436.6
Delivery %
3.39 %
Value
380.10 CR
ASM/GSM
No
Market Lot
1

Summary

RPG Life Sciences share price stands at ₹2295 at 30 Apr, 2026 | 15:49. The stock RPG Life Sciences intraday movement has stayed between ₹2049.90 and ₹2336.60, while on a 52-week basis it has fluctuated from ₹1733.00 to ₹2725.00.
In terms of trading activity, RPG Life Sciences has recorded a volume of 1683294 shares. The RPG Life Sciences has a market cap of ₹16539015. The stock’s Average Traded Price (ATP) stands at ₹225809, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 10, 229500.
The RPG Life Sciences operates within a circuit range of ₹1624.4-2436.6 – ₹1624.4-2436.6, with a Value of ₹380.10 CR. The Delivery Percentage for the day is 3.39%. Additionally, RPG Life Sciences currently falls under the No framework, and trades with a market lot size of 1.

RPG Life Sciences Fundamentals

View More
P/E Ratio

404.68

P/B Ratio

0

Div. Yield

1.19

Sector P/E

64.93

Sector P/B

3.52

Sec. Div. Yield

0.57

RPG Life Sciences Resistance and Support

Pivot 2227.17

Resistance

First Resistance

2404.44

Second Resistance

2513.87

Third Resistance

2691.14

Support

First Support

2117.74

Second Support

1940.47

Third Support

1831.04

RPG Life Sciences Shareholding Pattern

View More
  • 2016-17
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

72.95%

Mutual Fund

0.04%

Insurance

0.21%

Foreign Institutional Investors

0.87%

Domestic Institutional Investors

5.18%

Retail

20.75%

Others

0%

Total Promoters
MAR '26
72.95%

RPG Life Sciences Corporate Actions

DateAgenda
2026-04-29Audited Results & Final Dividend
2026-01-27Quarterly Results
2025-10-17Quarterly Results
2025-07-25Quarterly Results
2025-04-28Audited Results & Final Dividend
2025-01-24Quarterly Results

RPG Life Sciences News

RPG Life Sciences Limited

RPG LIFE SCIENCES recommended a final dividend of Rs.300 per equity share at its board meeting held on April 29, 2026. The record date for the dividend and the date for the Annual General Meeting (AGM) are yet to be fixed by the company.
Apr 29 2026 21:04:00

RPG Life Sciences Ltd - 532983 - Amendment To The Code

RPG Life Sciences Board approved Q4 & FY26 audited financial results and recommended a final dividend of Rs.24 per share for FY26, subject to shareholder approval. The board also appointed Dr. Pratit Samdani as an Additional Non-Executive Independent Director for five years.
Apr 29 2026 21:04:00

RPG Life Sciences Ltd - 532983 - Corporate Action-Board to consider Dividend

RPG Life Sciences' Board recommended a final dividend of ₹24 per equity share for FY26. This payout, 300% of face value, is subject to shareholder approval and will be dispatched within 30 days.
Apr 29 2026 20:04:00

RPG Life Sciences Ltd - 532983 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

RPG Life Sciences announced strong FY26 results with revenue growing 8.3% YoY to Rs. 707.5 cr and Q4 revenue up 23.6% to Rs. 176.9 cr. The board also recommended a Rs. 24 per share final dividend, reflecting healthy profitability and operational momentum.
Apr 29 2026 20:04:00

RPG Life Sciences Ltd - 532983 - Board Meeting Outcome for Outcome Of Board Meeting

RPG Life Sciences announced Q4 FY26 cons. revenue of ₹176.89 cr (up 23.62% YoY) and net profit of ₹29.90 cr (down 74.53% YoY). Full-year FY26 cons. revenue stood at ₹707.52 cr (up 8.28%) and net profit at ₹115.17 cr (down 37.15%). Additionally, the board recommended a final dividend of ₹24 per share for FY26.
Apr 29 2026 20:04:00

RPG Life Sciences Limited

RPG Life Sciences is holding an earnings call on April 30, 2026, at 3:30 PM IST. The call will cover the company's audited financial results for Q4 FY26 and the period ended March 31, 2026, with an investor presentation to follow.
Apr 23 2026 21:04:00

RPG Life Sciences Limited

RPG Life Sciences is holding an earnings call on April 30, 2026, at 3:30 PM IST. The call will cover the company's audited financial results for Q4 FY26 and the period ended March 31, 2026, with an investor presentation to follow.
Apr 23 2026 21:04:00

RPG Life Sciences Limited

RPG Life Sciences board will convene on April 29, 2026, to review and approve its audited standalone and consolidated financial results for the year ended March 2026. The meeting will also include consideration for recommending a final dividend.
Apr 22 2026 19:04:00

RPG Life Sciences Ltd - 532983 - Board Meeting Intimation for The Company Has Informed BSE That The Meeting Of The Board Of Directors Of The Company Is Scheduled On 29Th April, 2026

RPG Life Sciences' Board will meet on April 29, 2026, to approve audited financial results for Q4 FY26 and the full FY26. The meeting will also consider recommending a dividend for the financial year ended March 31, 2026.
Apr 22 2026 19:04:00

RPG Life Sciences Ltd - 532983 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

Clarus Capital I, a scheme of Clarus Trust, and PAC ClearEdge LLC acquired 0.88% equity in RPG Life Sciences Limited via open market. This increased their aggregate shareholding to 5.41%, crossing the disclosure threshold.
Apr 20 2026 13:04:00
Read More

About RPG Life Sciences

NSE : 16725  
BSE : 532983  
ISIN : INE105J01010  

RPG Life Sciences Management

NamePosition
Harsh GoenkaChairman
Ashok NairManaging Director
View More

RPG Life Sciences FAQs

The Buying Price of RPG Life Sciences share is 2295 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy RPG Life Sciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for RPG Life Sciences, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of RPG Life Sciences shares is 404.68. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio RPG Life Sciences shares is 0. Useful to assess the stock's value relative to its book value.

To assess RPG Life Sciences’s valuation compare Sector P/E, P/B which are 64.93 & 3.52 with sector averages, along with growth rates and financial metrics.

The Market Cap of RPG Life Sciences is 3795.70 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of RPG Life Sciences share price is 2725.00 & 1733.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

RPG Life Sciences belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost